BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 32876836)

  • 1. CMR T
    Zhao P; Huang L; Ran L; Tang D; Zhou X; Xia L
    Eur Radiol; 2021 Mar; 31(3):1206-1215. PubMed ID: 32876836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine chemical exchange saturation transfer (CEST) CMR imaging reveals myocardial early involvement in idiopathic inflammatory myopathy at 3T: feasibility and initial experience.
    Fan ZY; Lin YW; Shi RY; Yu LZ; Wu R; Yao QY; Wesemann LD; Hu J; Liu Q; Zhou Y; Chen S; Wu LM
    Eur Radiol; 2023 Jun; 33(6):3897-3907. PubMed ID: 36600121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Magnetic Resonance Mapping and Strain Assessment for the Diagnosis of Cardiac Involvement in Idiopathic Inflammatory Myopathy Patients With Preserved Left Ventricular Ejection Fraction.
    Wang Y; Wang Q; Cao J; Li X; Lin L; Chen W; Wang YN; Jin ZY
    J Thorac Imaging; 2021 Jul; 36(4):254-261. PubMed ID: 33560763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy.
    Xu Y; Sun J; Wan K; Yu L; Wang J; Li W; Yang F; Sun J; Cheng W; Mui D; Zhang Q; Xie Q; Chen Y
    J Cardiovasc Magn Reson; 2020 Apr; 22(1):22. PubMed ID: 32272936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping of myocardial involvement by cardiac magnetic resonance in idiopathic inflammatory myopathies.
    Sun J; Yin G; Xu Y; Wu Y; Yu L; Li W; Wan K; Sun J; Zhang Q; Xie Q; Chen Y
    Eur Radiol; 2021 Jul; 31(7):5077-5086. PubMed ID: 33409791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial involvement and deformation abnormalities in idiopathic inflammatory myopathy assessed by CMR feature tracking.
    Kersten J; Güleroglu AM; Rosenbohm A; Buckert D; Ludolph AC; Hackenbroch C; Beer M; Bernhardt P
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):597-603. PubMed ID: 32944886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping.
    Huber AT; Bravetti M; Lamy J; Bacoyannis T; Roux C; de Cesare A; Rigolet A; Benveniste O; Allenbach Y; Kerneis M; Cluzel P; Kachenoura N; Redheuil A
    J Cardiovasc Magn Reson; 2018 Feb; 20(1):11. PubMed ID: 29429407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy (IIM).
    Huber AT; Lamy J; Bravetti M; Bouazizi K; Bacoyannis T; Roux C; De Cesare A; Rigolet A; Benveniste O; Allenbach Y; Kerneis M; Cluzel P; Redheuil A; Kachenoura N
    Eur Radiol; 2019 Oct; 29(10):5139-5147. PubMed ID: 30847587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of myocardial involvement by T
    Yu L; Sun J; Sun J; Li J; Dong Y; Zhou X; Greiser A; Han Y; Zhang Q; Xie Q; Chen Y
    J Magn Reson Imaging; 2018 Aug; 48(2):415-422. PubMed ID: 29328539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer.
    Thavendiranathan P; Shalmon T; Fan CS; Houbois C; Amir E; Thevakumaran Y; Somerset E; Malowany JM; Urzua-Fresno C; Yip P; McIntosh C; Sussman MS; Brezden-Masley C; Yan AT; Koch CA; Spiller N; Abdel-Qadir H; Power C; Hanneman K; Wintersperger BJ
    JAMA Cardiol; 2023 Jun; 8(6):524-534. PubMed ID: 37043251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
    Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early cardiac involvement detected by cardiac magnetic resonance feature tracking in idiopathic inflammatory myopathy with preserved ejection fraction.
    Liu W; Zhu Y; Feng C; Zhu X; Xu Y; Shi H
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):183-194. PubMed ID: 36112253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.